宫颈癌Ⅱ_b患者术中大剂量放疗前后T细胞亚群水平的变化

目的　探讨术中放疗对宫颈癌Ⅱb 患者细胞免疫功能的影响。方法　在放疗前后,用流式细胞技术检测61 例宫颈癌Ⅱb 患者T淋巴细胞亚群水平(包括CD4、CD8、CD4/CD8)的变化。其中28 例行术中放疗(IROT),33 例行单纯放疗(SR),并与20例正常人作对照。结果　单纯放疗组和术中放疗组在放疗前CD4,CD4/CD8 均明显低于正常组(P<0.001),而前两组间CD4、CD8、CD4/CD8 无显著性差异;放疗后两组CD4、CD4/CD8 较放疗前均下降,CD8 上升,单纯放疗组CD4、CD4/CD8 明显低于术中放疗组(P<0.05)。结论　与单纯放疗相比,宫颈癌术中大剂量放疗对患者免疫系统的影响较轻,有利于机体的恢复。

The changes of T-lymphocytes subsets in patients with cervical cancer at Ⅱb stage before and after interoperation heavy radiation therapy

Objective To investigate the influence of interoperation radiation therapy (IROT) on immunity of patients with cervical cancer at Ⅱ b stage. Methods Before and after radiotherapy, T lymphocyte subsets of 61 cervical cancer patients at Ⅱ b stage including 28 patients with IROT and 31 with simple radiotherapy (SR) were tested by flow cytometry, with 20 normal people as the controls(NC). Results Before radiotherapy, radio CD 4, CD 4/CD 8 decreased obviously in cervical cancer patients. There was no obvious difference in immunity between IROT and SR group. After radiotherapy, radio CD 4, CD 4/CD 8 decreased obviously in 61 cervical cancer patients. But SR group was significantly lower than IROT group. Conclusion The influence of IROT on immunity of patients with cervical cancer at Ⅱ b stage was weaker than that of simple radiotherapy, and IROT contributed to the recovery of patients after radiotherapy.